PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Protein Folding and Misfolding: It's the Journey, Not the Destination
March 2015
CCR5 and HIV Infection
January 2015
HIV/AIDS: Pre-fusion Env Exposed
January 2015
HIV/AIDS: Slide to Enter
January 2015
Updating ModBase
January 2015
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Bacterial CDI Toxins
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Virology: A Bat Influenza Hemagglutinin
March 2014
Virology: Making Sensitive Magic
March 2014
Virology: Visualizing Cyanophage Assembly
March 2014
Virology: Zeroing in on HBV Egress
March 2014
Viroporins
March 2014
Cas4 Nuclease and Bacterial Immunity
February 2014
Microbial Pathogenesis: A GNAT from Pseudomonas
February 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Microbiome: The Dynamics of Infection
September 2013
Membrane Proteome: A Funnel-like Viroporin
August 2013
Infectious Diseases: A Pathogen Ubiquitin Ligase
May 2013
Infectious Diseases: A Shared Syringe
May 2013
Infectious Diseases: Determining the Essential Structome
May 2013
Infectious Diseases: Targeting Meningitis
May 2013
NDM-1 and Antibiotics
May 2013
Bacterial Hemophores
January 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Microbial Pathogenesis: NEAT Iron
January 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
A signal sensing switch
September 2012
Gauging needle structure
July 2012
Anthrax Stealth Siderophores
June 2012
A Pseudomonas L-serine dehydrogenase
May 2012
Pilus Assembly Protein TadZ
April 2012
Making Lipopolysaccharide
January 2012
Superbugs and Antibiotic Resistance
December 2011
A change to resistance
November 2011
An effective and cooperative dimer
November 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
Breaking down the defenses
September 2011
Moving some metal
August 2011
Capsid assembly in motion
April 2011
Know thy enemy … structurally
October 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Hemolysin BL
January 2010
Unusual cell division
October 2009
Anthrax evasion tactics
September 2009
Toxin-antitoxin VapBC-5
September 2009
Antibiotic target
August 2009
Lysostaphin
July 2009
Tackling influenza
June 2009
You look familiar: the Type VI secretion system
June 2009
Unique SARS
April 2009
Anthrax stealth molecule
March 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Antiviral evasion
October 2008
SARS connections
September 2008
SARS Coronavirus Nonstructural Protein 1
June 2008

Research Themes Infectious diseases

Viroporins

SBKB [doi:10.3942/psi_sgkb/fm_2014_3]
Featured System - March 2014
Short description: PSI researchers have determined the structures of several viral pore-forming proteins, revealing common functional features.

Viruses always seem to find streamlined ways of doing things. Their enzymes are often multifunctional and more compact than their cellular counterparts, and overlapping genes allow them to pack a lot of genetic information into a small space. They have also found a very parsimonious way of creating membrane channels. These simple channels, termed viroporins, are stripped to the bare minimum, with just enough molecular machinery to perform their membrane-spanning function.

Funneling Calcium

The p7 protein of the hepatitis C virus, shown here from PDB entry 2m6x, is a perfect example. PSI researchers at MPSbyNMR have recently solved the structure of the channel using NMR spectroscopy. The structure reveals a compact funnel-shaped pore composed of six identical chains, each only 63 amino acids long. The funnel constricts down to a ring of asparagine amino acids, which together form a selectivity ring that may favor the passage of calcium ions over other ions like sodium or potassium.

Elusive Functions

Viroporins are essential for efficient infectivity, but their exact functional roles are still a subject of study and debate. They may be important for disrupting the normal ion balance of the cell, especially as new viruses are exiting from the infected cell. They may also be important for allowing passage of ions into and out of the virus, so that it can sense when it is inside a cell and ready to release its genome. In addition, they often also act as scaffolds, interacting with other cellular and viral proteins and holding them near to the membrane. All of these hypotheses are the subject of current research, to try to uncover the varied roles these viroporins are playing in different viruses.

Viroporin Diversity

Membrane-spanning channels have been discovered in many viruses. Three examples are shown here. The hepatitis C p7 channel is shown at the bottom, composed of six identical chains. Two even more compact proteins are shown at the top. The M2 protein of influenza (PDB entry 2rlf) is composed of four identical chains, each forming a single alpha helix that passes through the membrane. It is selective for the passage of protons through the membrane. The membrane-spanning portion of Vpu from HIV-1 (PDB entry 1pi7) is composed of five identical chains, and forms a weakly-selective ion pore.

Inhibiting Viroporins

Given their essential function in viral infectivity, researchers have searched for inhibitors of viroporins to use as antiviral drugs. Amantadine compounds were an early success. They are shaped like a little ball that lodges in the channel, as seen in this structure of influenza M2 protein (PDB entry 2ljc). Unfortunately, viruses have rapidly developed resistance to these drugs, so they are not effective with most strains. To explore this structure in more detail, click on the JSmol tab for an interactive Jmol. (Best viewed in Firofox)

Influenza Virus M2 (PDB entry 2ljc)

The M2 protein from influenza virus is composed of four short protein chains that form a channel through membranes. Use the buttons to display the inhibitor rimantadine, which blocks the channel, and two key amino acids that define the characteristics of the channel: a histidine (in turquoise) that transports protons through the channel, and a tryptophan (magenta) that forms a gate that blocks larger molecules from passing. (best viewed in Firofox - if low res image loads, click on it to load hi-res image)

References

  1. OuYang, B. & Chou, J. J. The minimalist architectures of viroporins and their therapeutic implications. Biochim. Biophys. Acta (2013) http://dx.doi.org/10.1016/j.bbamem.2013.09.004.

  2. OuYang, B., et al. Unusual architecture of the p7 channel from hepatitis C virus. Nature 498, 521-525.

  3. Nieva, J. L., Madan, V. & Carrasco, L. Viroporins: structure and biological functions. Nature Rev. Microbio. 10, 563-574 (2012).

  4. Pielak, R. M., Oxenoid, K. & Chou, J. J. Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses. Structure 19, 1655- 1663 (2011).

  5. Schnell, J. R. & Chou, J. J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451, 591-595 (2008).

  6. Park, S. H. et al. Structure of the channel-forming trans-membrane domain of the virus protein "u" (Vpu) from HIV-1. J. Mol. Biol. 333, 409-424 (2003).

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health